Publications by authors named "Noel Clarke"

100Publications

Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: a national population-based study.

Radiother Oncol 2020 Oct 16. Epub 2020 Oct 16.

Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, England; Department of Cancer Epidemiology, Population, and Global Health, King's College London, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2020.10.019DOI Listing
October 2020

Re: Hiten D. Patel, Farzana A. Faisal, Bruce J. Trock, et al. Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. Eur Urol 2020;78:360-8.

Eur Urol 2020 Oct 3. Epub 2020 Oct 3.

Department of Urology, The Christie NHS Foundation Trusts, Manchester, UK; Department of Urology, Salford Royal NHS Foundation Trusts, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2020.09.038DOI Listing
October 2020

Toxicity of Pelvic Lymph Node Irradiation With Intensity Modulated Radiation Therapy for High-Risk and Locally Advanced Prostate Cancer: A National Population-Based Study Using Patient-Reported Outcomes.

Int J Radiat Oncol Biol Phys 2020 Jul 24. Epub 2020 Jul 24.

Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Department of Cancer Epidemiology, Population, and Global Health, King's College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2020.07.031DOI Listing
July 2020

A Call for Standardized Reporting of Adverse Events.

Eur Urol 2020 Sep 4;78(3):481-482. Epub 2020 Jul 4.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2020.06.052DOI Listing
September 2020

The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE's "M1|RT Comparison".

Eur Urol Oncol 2020 Aug 24;3(4):412-419. Epub 2020 Jun 24.

Genito-Urinary Cancer Research Group, Division of Cancer Sciences, The University of Manchester, Manchester, UK; FASTMAN Centre of Prostate Cancer Excellence, Manchester Cancer Research Centre, Manchester, UK; Department of Surgery, The Christie NHS Foundation Trust, Manchester, UK; Department of Urology, The Salford NHS Foundation Trust, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2020.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443695PMC
August 2020

Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.

BMC Nephrol 2020 May 29;21(1):202. Epub 2020 May 29.

Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, M6 8HD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12882-020-01859-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257121PMC
May 2020

Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study.

BJU Int 2020 Jul 6;126(1):97-103. Epub 2020 Apr 6.

Department of Urology, Christie and Salford Royal Hospitals Manchester NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.15039DOI Listing
July 2020

Reply by Authors.

J Urol 2020 05 31;203(5):956. Epub 2020 Jan 31.

Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JU.0000000000000705.03DOI Listing
May 2020

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.

Eur Urol 2020 04 27;77(4):508-547. Epub 2020 Jan 27.

University of Bern, Bern, Switzerland; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2020.01.012DOI Listing
April 2020

Identifying skeletal-related events for prostate cancer patients in routinely collected hospital data.

Cancer Epidemiol 2019 12 9;63:101628. Epub 2019 Nov 9.

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2019.101628DOI Listing
December 2019

Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling.

Nat Commun 2019 11 1;10(1):5016. Epub 2019 Nov 1.

Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Wilmslow Road, Manchester, M20 4GJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-12807-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825219PMC
November 2019

Prostate radiotherapy in newly diagnosed metastatic prostate cancer.

Curr Opin Urol 2019 11;29(6):620-628

Genito-Urinary Cancer Research Group and the FASTMAN Prostate Cancer Centre for Excellence, Division of Cancer Sciences, Manchester Cancer Research Centre, The University of Manchester, Manchester.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000675DOI Listing
November 2019

Radiotherapy for metastatic prostate cancer-Authors' reply.

Lancet 2019 09;394(10201):830

Medical Research Council Clinical Trials Unit at University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31829-XDOI Listing
September 2019

Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.

Eur Urol 2019 12 23;76(6):719-728. Epub 2019 Aug 23.

The Christie and Royal Salford Hospitals, Manchester, UK; Genito Urinary Cancer Research Group and the FASTMAN Centre of Excellence, Division of Cancer Sciences, The University of Manchester, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838193062
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2019.08.006DOI Listing
December 2019

Multiple primary malignancies associated with a germline SMARCB1 pathogenic variant.

Fam Cancer 2019 10;18(4):445-449

Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals Foundation Trust, Manchester, M13 9WL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-019-00138-4DOI Listing
October 2019

Re: David W. Donnelly, Anna Gavin, Amy Downing, et al. Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom. Eur Urol 2019;76:228-37.

Eur Urol 2020 03 15;77(3):e65. Epub 2019 Jun 15.

National Prostate Cancer Audit, London, UK; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.06.001DOI Listing
March 2020

Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer.

Eur Urol Oncol 2019 02 5;2(1):1-11. Epub 2018 Sep 5.

Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Prostate Oncobiology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2018.08.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472613PMC
February 2019

Impact of patient choice and hospital competition on patient outcomes after prostate cancer surgery: A national population-based study.

Cancer 2019 06 1;125(11):1898-1907. Epub 2019 Feb 1.

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31987DOI Listing
June 2019

Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer.

Cell Rep 2018 12;25(12):3504-3518.e6

Prostate Oncobiology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park SK10 4TG, UK; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park SK10 4TG, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22111247183184
Publisher Site
http://dx.doi.org/10.1016/j.celrep.2018.11.069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315111PMC
December 2018

Imputation of missing prostate cancer stage in English cancer registry data based on clinical assumptions.

Cancer Epidemiol 2019 02 18;58:44-51. Epub 2018 Nov 18.

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, England, United Kingdom; Clinical Effectiveness Unit, The Royal College of Surgeons of England, 35-43 Lincoln's Inn Fields, London, WC2A 3PE, England, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2018.11.003DOI Listing
February 2019

Is combining PARP and androgen receptor inhibition really a winning strategy in metastatic castration-resistant prostate cancer? - Authors' reply.

Authors:
Noel Clarke

Lancet Oncol 2018 09;19(9):e438

The Christie and Salford Royal Hospitals, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30616-8DOI Listing
September 2018

Mapping Hypoxia in Renal Carcinoma with Oxygen-enhanced MRI: Comparison with Intrinsic Susceptibility MRI and Pathology.

Radiology 2018 09 5;288(3):739-747. Epub 2018 Jun 5.

From the Centre for Imaging Sciences (R.A.L., J.H.N., Y.W., S.C., K.F.H., H.L., D.J.M., G.J.M.P., J.C.W.) and Division of Cancer Sciences (J.I., C.M.L.W., N.W.C., J.P.B.O.), University of Manchester, Manchester, England; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, England (Y.J., J.K.R.B., S.P.R.); Department of Pathology, Central Manchester University Hospitals NHS Foundation Trust, Manchester, England (G.N.B.); Department of Histology, CRUK Manchester Institute, Manchester, England (G.A.); Tumour Biology Team, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England (A.R.R.); Department of Urology, Salford Royal Hospitals NHS Foundation Trust, Salford, England (S.M., N.W.C.); Bioxydyn Ltd, Manchester, England (G.J.M.P., J.C.W.); and Department of Radiology, The Christie NHS Foundation Trust, Manchester, England (J.P.B.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2018171531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122194PMC
September 2018

Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.

BJU Int 2019 01 13;123(1):65-73. Epub 2018 Jun 13.

Genito-Urinary Cancer Research Group, Division of Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14400DOI Listing
January 2019

Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study.

Radiother Oncol 2018 08 14;128(2):357-363. Epub 2018 May 14.

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2018.04.032DOI Listing
August 2018

Primary Mutational Landscape Linked with Pre-Docetaxel Lactate Dehydrogenase Levels Predicts Docetaxel Response in Metastatic Castrate-Resistant Prostate Cancer.

Eur Urol Focus 2019 Sep 24;5(5):831-841. Epub 2018 Apr 24.

Genito Urinary Cancer Research Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, UK; Department of Urology, Salford Royal NHS Foundation Trust, Manchester, UK; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; FASTMAN, Prostate Cancer UK, Movember Centre of Excellence, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2018.04.006DOI Listing
September 2019

Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform.

BJU Int 2018 05 28;121(5):680-683. Epub 2018 Feb 28.

MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14153DOI Listing
May 2018

National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.

Int J Radiat Oncol Biol Phys 2017 12 1;99(5):1253-1260. Epub 2017 Sep 1.

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.07.040DOI Listing
December 2017

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.

J Clin Oncol 2017 09 10;35(27):3097-3104. Epub 2017 Aug 10.

Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.9987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652387PMC
September 2017

Determinants of Patient Mobility for Prostate Cancer Surgery: A Population-based Study of Choice and Competition.

Eur Urol 2018 06 29;73(6):822-825. Epub 2017 Jul 29.

Department of Health Services Research & Policy, London School of Hygiene and Tropical Medicine, London, England, UK; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, England, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.07.013DOI Listing
June 2018

Magnetic Resonance Imaging and Detection of Metastases in Prostate Cancer: Learning Lessons from History.

Eur Urol 2018 01 8;73(1):92-93. Epub 2017 Jun 8.

The Christie and Salford Royal Hospitals, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.05.052DOI Listing
January 2018

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

N Engl J Med 2017 07 3;377(4):338-351. Epub 2017 Jun 3.

From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1702900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533216PMC
July 2017

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.

J Clin Oncol 2017 May 13;35(14):1530-1541. Epub 2017 Mar 13.

Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455701PMC
May 2017

Identification and evaluation of clinically significant prostate cancer: a step towards personalized diagnosis.

Curr Opin Urol 2017 May;27(3):217-224

aProstate Oncobiology bCancer Research UK Manchester Institute cBelfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, University of Manchester dDepartment of Surgery, The Christie NHS Foundation Trust, Manchester eDepartment of Urology, Salford NHS Foundation Trust, Salford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000385DOI Listing
May 2017

Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.

Eur Urol 2017 11 8;72(5):689-709. Epub 2017 Feb 8.

Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.01.039DOI Listing
November 2017

Infrared spectral histopathology using haematoxylin and eosin (H&E) stained glass slides: a major step forward towards clinical translation.

Analyst 2017 Apr;142(8):1258-1268

Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

View Article

Download full-text PDF

Source
http://xlink.rsc.org/?DOI=C6AN02224C
Publisher Site
http://dx.doi.org/10.1039/c6an02224cDOI Listing
April 2017

STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' reply.

Lancet 2016 Jul;388(10041):235-6

Medical Research Council, Clinical Trials Unit, University College London, London WC2B 6NH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)31041-8DOI Listing
July 2016

Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform.

Eur Urol 2016 12 19;70(6):906-908. Epub 2016 Jul 19.

Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.07.015DOI Listing
December 2016

High-throughput quantum cascade laser (QCL) spectral histopathology: a practical approach towards clinical translation.

Faraday Discuss 2016 06;187:135-54

Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c5fd00176eDOI Listing
June 2016

Stroma-induced Jagged1 expression drives PC3 prostate cancer cell migration; disparate effects of RIP-generated proteolytic fragments on cell behaviour and Notch signaling.

Biochem Biophys Res Commun 2016 Mar 26;472(1):255-61. Epub 2016 Feb 26.

Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, LA1 4YQ, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2016.02.101DOI Listing
March 2016

Cardiovascular risk with androgen deprivation therapy for prostate cancer: potential mechanisms.

Urol Oncol 2015 Nov 30;33(11):464-75. Epub 2015 Jun 30.

Department of Clinical Sciences, Lund University, Malmö, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.05.030DOI Listing
November 2015

External urethral sphincter electromyography in asymptomatic women and the influence of the menstrual cycle.

BJU Int 2015 Sep 4;116(3):423-31. Epub 2015 May 4.

Department of Urology, Salford Royal NHS Foundation Trust, Salford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13042DOI Listing
September 2015

Is it safe to insert a testicular prosthesis at the time of radical orchidectomy for testis cancer: an audit of 904 men undergoing radical orchidectomy.

BJU Int 2016 Feb 25;117(2):249-52. Epub 2015 May 25.

Department of Urology, The Christie NHS Foundation Trust, University Hospital of South Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12920DOI Listing
February 2016

Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells.

BMC Cancer 2014 Mar 28;14:226. Epub 2014 Mar 28.

Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester Cancer Research Centre, Manchester M20 4BX, UK.

View Article

Download full-text PDF

Source
http://bmccancer.biomedcentral.com/articles/10.1186/1471-240
Publisher Site
http://dx.doi.org/10.1186/1471-2407-14-226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977890PMC
March 2014

Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?

BJU Int 2015 Mar 15;115(3):364-72. Epub 2014 Jul 15.

University Hospital, Saint Etienne, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12736DOI Listing
March 2015

Quantification of skeletal metastases in castrate-resistant prostate cancer predicts progression-free and overall survival.

BJU Int 2014 Dec 27;114(6b):E70-E73. Epub 2014 Jul 27.

Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.12717
Publisher Site
http://dx.doi.org/10.1111/bju.12717DOI Listing
December 2014

Assessing the challenges of Fourier transform infrared spectroscopic analysis of blood serum.

J Biophotonics 2014 Apr 31;7(3-4):180-8. Epub 2014 Jan 31.

Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK; Genito Urinary Cancer Research Group, Institute of Cancer Sciences, Paterson Building, The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.201300167DOI Listing
April 2014

The Melbourne Consensus Statement on the early detection of prostate cancer.

BJU Int 2014 Feb;113(2):186-8

Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic., Australia; Royal Melbourne Hospital, University of Melbourne, Melbourne, Vic., Australia; Epworth Prostate Centre, Australian Prostate Cancer Research Centre, Epworth Healthcare Richmond, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12556DOI Listing
February 2014

Whole organ cross-section chemical imaging using label-free mega-mosaic FTIR microscopy.

Analyst 2013 Dec 9;138(23):7066-9. Epub 2013 Oct 9.

Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c3an01674aDOI Listing
December 2013

Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma.

Clin Epigenetics 2013 Sep 13;5(1):16. Epub 2013 Sep 13.

Centre for Rare Diseases and Personalised Medicine, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1868-7083-5-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848591PMC
September 2013

UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor gene.

Hum Mutat 2013 Dec 7;34(12):1650-61. Epub 2013 Oct 7.

Centre for Rare Diseases and Personalised Medicine, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.22433DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028990PMC
December 2013

Balancing toxicity and efficacy: learning from trials and treatment using antiresorptive therapy in prostate cancer.

Authors:
Noel W Clarke

Eur Urol 2014 Feb 26;65(2):287-8. Epub 2013 Jul 26.

The Christie and Salford Royal Hospitals, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2013.07.026DOI Listing
February 2014

Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.

Endocr Relat Cancer 2013 Feb 18;20(1):137-49. Epub 2013 Feb 18.

Service of Urology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon 46, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-12-0286DOI Listing
February 2013

FTIR microspectroscopy of selected rare diverse sub-variants of carcinoma of the urinary bladder.

J Biophotonics 2013 Jan 2;6(1):73-87. Epub 2012 Nov 2.

Manchester Institute of Biotechnology, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.201200126DOI Listing
January 2013

Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer.

Authors:
Noel W Clarke

BJU Int 2012 Oct;110 Suppl 1:14-22

The Christie and Salford Royal Hospitals, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11430.xDOI Listing
October 2012

Coming up for air: follow-up and risk stratification after negative prostate cancer screening.

Authors:
Noel W Clarke

Eur Urol 2013 Apr 13;63(4):634-5; discussion 635-6. Epub 2012 Aug 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2012.08.007DOI Listing
April 2013

FTIR microscopy of biological cells and tissue: data analysis using resonant Mie scattering (RMieS) EMSC algorithm.

Analyst 2012 Mar 9;137(6):1370-7. Epub 2012 Feb 9.

Manchester Interdisciplinary Biocentre, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c2an16088aDOI Listing
March 2012

Targeted caval cytoreduction: solid foundations or shifting sands?

Eur Urol 2011 Jun 21;59(6):919-20; discussion 921-2. Epub 2011 Mar 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2011.03.018DOI Listing
June 2011

Is population screening for prostate cancer good or bad?

Authors:
Noel W Clarke

Eur Urol 2011 Mar 1;59(3):363-4. Epub 2010 Dec 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2010.11.027DOI Listing
March 2011

SR-FTIR spectroscopy of renal epithelial carcinoma side population cells displaying stem cell-like characteristics.

Analyst 2010 Dec 27;135(12):3133-41. Epub 2010 Oct 27.

Manchester Interdisciplinary Biocentre, University of Manchester, 131 Princess Street, Manchester, UK M1 7DN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c0an00574fDOI Listing
December 2010